Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain (PhyDoNe)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01053845|
Recruitment Status : Completed
First Posted : January 21, 2010
Last Update Posted : July 8, 2014
Several studies showed that activity of down inhibitor bundle is weakened in different painful pathologies as the fibromyalgy or the trigeminal nevralgy.
The purpose of the protocol is to study the working of down inhibitor bundle at patients suffering of neuropathic pain.
|Condition or disease||Intervention/treatment||Phase|
|Healthy Volunteers Patients Suffering of Peripheral Neuropathic Pain||Other: Neuropathic pain||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain|
|Study Start Date :||April 2010|
|Actual Primary Completion Date :||May 2011|
|Actual Study Completion Date :||May 2011|
- Other: Neuropathic pain
to study the working of down inhibitor bundle at patients suffering of neuropathic pain
- Comparison of the amplitude of N2P2 waves between healthy volunteers and patients suffering of peripheral neuropathic pain.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01053845
|Clermont-Ferrand, France, 63003|
|Principal Investigator:||Gisèle Pickering, Dr||University Hospital, Clermont-Ferrand|